Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review ; volume:21 ; number:1 ; day:28 ; month:8 ; year:2021 ; pages:1-16 ; date:12.2021
BMC cancer ; 21, Heft 1 (28.8.2021), 1-16, 12.2021
- Creator
-
Hackshaw, Michelle D.
Danysh, Heather E.
Henderson, Mackenzie
Wang, Eric
Tu, Nora
Islam, Zahidul
Ladner, Amy
Ritchey, Mary E.
Salas, Maribel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-021-08708-5
- URN
-
urn:nbn:de:101:1-2021111306390641399332
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hackshaw, Michelle D.
- Danysh, Heather E.
- Henderson, Mackenzie
- Wang, Eric
- Tu, Nora
- Islam, Zahidul
- Ladner, Amy
- Ritchey, Mary E.
- Salas, Maribel
- SpringerLink (Online service)
Other Objects (12)
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018: highlights in HER2-positive metastatic breast cancer
Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
SIRT6 promotes metastasis and relapse in HER2-positive breast cancer
Appendicitis caused by the metastasis of HER2-positive breast cancer
Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018: highlights in HER2-positive metastatic breast cancer
Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
SIRT6 promotes metastasis and relapse in HER2-positive breast cancer
Appendicitis caused by the metastasis of HER2-positive breast cancer
Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018: highlights in HER2-positive metastatic breast cancer
Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
SIRT6 promotes metastasis and relapse in HER2-positive breast cancer
Appendicitis caused by the metastasis of HER2-positive breast cancer
Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study